Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 12 Giant Cell Tumor of Bone 10 Prostatic Neoplasms 9 Multiple Myeloma 9 Neoplasm Metastasis 8 Osteoporosis 4 Fractures, Bone 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Kidney Neoplasms 3 Carcinoma, Renal Cell 3 Bone Neoplasms 3 Bone Diseases, Metabolic 3 Bone Diseases 3 Spinal Cord Compression 2 Smoldering Multiple Myeloma 2 Parathyroid Neoplasms 2 Melanoma 2 Lymphoma 2 Lung Neoplasms 2 Giant Cell Tumors 2 Bone Metastases 2 Bone Cysts, Aneurysmal 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer Metastatic 1 Paraproteinemias 1

Interventions

Anastrozole 8 exemestane 7 Trastuzumab 7 Letrozole 7 palbociclib 6 Docetaxel 6 abemaciclib 5 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 Cyclophosphamide 4 Tamoxifen 3 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Denosumab × Clear all

NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡